DETAILED NOTES ON LYCORINE

CRC has an immunosuppressive TME which helps prevent the development of a successful response to ICB therapies. There may be Therefore an urgent should discover the means reprogram this suppressive TME as a way to enrich immunotherapy efficacy. In The present review, we made use of CRISPR KO screens to discover genes that sensitize CRC to antitumor